trulyThe health data in Alphabet and AI received a $ 14.7 million research grant from Michael J
This effort will integrate advanced molecular stereotypes with a wide range of clinical data, photography and wearing collected through the Pencorson Project (PPP).
The PPP is a two -year longitudinal study conducted in cooperation with the Medical Center of Radbod University, and included 520 individuals who were diagnosed with Parkinson’s injury.
The study acquired multimedia data collections, including biospiceimens, clinical history, photography and physiological data.
Dr. Andrew Tree, the chief medical and scientific official of Verily, told Verily, Mobihealthnews That throughout the study period, the participants wore a continuous monitoring of Verily and completed virtual mobility exams.
“This, in addition to photography and clinical data, helped to verify the authenticity of the use of digital measures in Parkinson’s research,” he said.
It also provides detailed profiles on the health of the participants and the development of the disease over time, which can be used in the visible end disease and improve the end of the clinical experience of the development of treatment.
“We will use multiple laboratory methods to create the most detailed molecular data collection for a group of GD so far.”
This includes Verily Profile Xseq with a full 30x genome sequence (for the participants who agreed) as well as cytokin, metabolism and αlpha-synuclein.
Funding will be used to perform a high -resolution molecular analysis on the current BIOSPECIMEN Bank, which includes fluid samples in the blood and cellular.
“Our approach to molecular analysis is informed by our experience in supporting researchers working on projects such as AMP-PD, which provides one uniform environment to analyze multiple complex data from groups, including data from the MJFF PPMI study,” said Trister.
The resulting data collection will include a complete genome sequence, metabolism, vital signs of alpha-cineockelin and immune data. The data set is expected to support new visions of the disease mechanisms, improve diagnoses and facilitate the development of targeted treatments.
These layers aim to improve the understanding of genetic paths, metabolism and immunity participating in causing Parkinson’s disease and its development.
Data will be accessed for the public to the research community via Ferily Workbench, a cloud -based environment to manage and analyze biomedical data collections on a large scale.
Researchers will be able to use the basic system for men and analyze molecular data associated with Parkinson’s Parkinson, along with other hosted data collections.
Rister Noted Verily has worked with MJFF via many collaborators, including a partnership in the MJFFINSONSONSONSONSORSSION Markers (PPMI) initiative, through which Verily presented its study of a two -year sub -study that focuses on generating digital measures.
Ferily’s Workbench also supports MJFF through many programs, including with collaborators such as the Parkinson (ASAP) initiative and its resource program in the Global Parkinson (GP2) and the data sharing tool, The Crn Cloud, with a more scheme.
“This grant adds a new dimension to the previous cooperation by providing a new molecular data resource that will help researchers all over the world understand the genetic, immune and molecular properties of PD along with various data elements already available in the PPP data group.”